Wendell Amy McBride's Form 4 filing
Axogen, Inc. (AXGN) · filed Dec 17, 2025
- Accession no.
- 0001400568-25-000005
- Filed
- Dec 17, 2025
- Trade date
- Dec 16, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.28M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wendell Amy McBrideCIK 0001400568 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Common Stock | MOption exerciseAcquired | +5,000 | $8.95 | +$44,750 | 98,826 | Direct | |
| Dec 16, 2025 | Common Stock | MOption exerciseAcquired | +20,436 | $6.30 | +$128,746.8 | 119,262 | Direct | |
| Dec 16, 2025 | Common Stock | MOption exerciseAcquired | +18,248 | $7.04 | +$128,465.92 | 137,510 | Direct | |
| Dec 16, 2025 | Common Stock | SSaleDisposed | −5,000 | $29.31F1 | −$146,550 | 132,510 | Direct | |
| Dec 16, 2025 | Common Stock | SSaleDisposed | −20,436 | $29.31F1 | −$598,979.16 | 112,074 | Direct | |
| Dec 16, 2025 | Common Stock | SSaleDisposed | −18,248 | $29.31F1 | −$534,848.88 | 93,826 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 0 | Direct | |
| Dec 16, 2025 | Common Stock | MOption exerciseDisposed | −20,436 | $0.00 | $0 | 0 | Direct | |
| Dec 16, 2025 | Common Stock | MOption exerciseDisposed | −18,248 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 3 transactions in Table I.